# Bristol-Myers Squibb Company (BMY) — Q3-2010 Earnings Results

**Report date:** 2010-10-26 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q3-2010

## Post-Earnings Brief

### Headline

Bristol-Myers Squibb Beats on EPS, Stock Down 1.1%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.59 | N/A | +11.11% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record for this earnings call, so the analysis is based solely on numerical results.

### Guidance Changes

No forward guidance data is available for this quarter.

### What It Means

Bristol-Myers Squibb reported a better-than-expected EPS, which indicates some positive performance in their operations. However, the stock fell by 1.1%, suggesting that investors may have been looking for more comprehensive revenue details or guidance. The lack of additional information from the earnings call may have contributed to the stock's decline.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q3-2010_